Martha Arnold

Principal Martha Arnold brings extensive experience in cross-functional development team activities, working closely with clinical, regulatory and scientific experts to move candidates through all stages of the product lifecycle. She possesses over 25 years’ experience in facilitating marketing and regulatory communications for pharmaceutical firms. While at PharmApprove, she has spearheaded over 45 Advisory Committee preparation and pre-submission strategy projects. Earlier in her career, she advised Kyowa Pharmaceutical on commercial, marketing, and regulatory strategy for a novel agent for Parkinson’s disease. As Senior Vice President at Anesta Corp, she led teams for the novel opioid analgesic Actiq.  Martha began her career at Johnson & Johnson, where she led the company through regulatory and marketing challenges arising with Rx to OTC switches. Martha received her MBA from the University of Chicago School of Business and is a graduate of the University of Virginia.